Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,070 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 601-625 of 796 matching filings.

Per page
25
Current page
25
8-K File 000-09410

8-K

Filing date
30 Apr 2014
Reporting date
30 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-182476

424B5

Filing date
30 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-09410

8-A12G

Filing date
30 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-187803

424B3

Filing date
30 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

8-K

Filing date
30 Apr 2014
Reporting date
28 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-09410

DEF 14A

Filing date
30 Apr 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-09410

PRE 14A

Filing date
18 Apr 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-215835

D filing

Filing date
17 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2014
Reporting date
20 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

8-K

Filing date
24 Mar 2014
Reporting date
24 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS BIOPHARMACEUTICALS, INC. 8-K MARCH 21, 2014

Filing date
21 Mar 2014
Reporting date
21 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2014
Reporting date
26 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2014
Reporting date
26 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS BIOPHARMACEUTICALS, INC. 8-K JANUARY 24, 2014

Filing date
24 Jan 2014
Reporting date
24 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS BIOPHARMACEUTICALS, INC.

Filing date
24 Jan 2014
Reporting date
23 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS BIOPHARMACEUTICALS, INC. 8-K JANUARY 15, 2014

Filing date
15 Jan 2014
Reporting date
15 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

8-K

Filing date
18 Dec 2013
Reporting date
18 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC. 8-K DECEMBER 16, 2013

Filing date
17 Dec 2013
Reporting date
16 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-09410

NOTICE AND PROXY STATEMENT

Filing date
15 Nov 2013
Reporting date
16 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-187803

424B3

Filing date
12 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-09410

PRE 14A

Filing date
05 Nov 2013
Reporting date
16 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC. 8-K OCTOBER 24, 2013

Filing date
24 Oct 2013
Reporting date
24 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .